Back

Isolation of Biologically Active Extracellular Vesicles-Associated AAVs for Gene Delivery to the Brain by Size Exclusion Chromatography

Henriques, C.; Lopes, M. M.; Albuquerque, P.; Rufino-Ramos, D.; Gaspar, L. S.; Lobo, D.; Leandro, K.; Silva, A. C.; Baganha, R.; Duarte, S.; Maguire, C. A.; Santana, M.; Pereira de Almeida, L.; Nobre, R. J.

2023-05-30 molecular biology
10.1101/2023.05.30.542901 bioRxiv
Show abstract

Extracellular vesicles-associated adeno-associated viral vectors (EV-AAVs) emerged as a new opportunity for non-invasive gene therapy targeting the central nervous system (CNS). However, in previous reports, only AAV serotypes with known ability to cross the blood-brain barrier (BBB) have been used for EV-AAV production and testing through non-invasive strategies. In this work, we aimed at optimizing a size exclusion chromatography (SEC) protocol for the production and isolation of natural and biologically active brain-targeting EV-AAVs, that could be applied to any AAV serotype and further used for non-invasive gene delivery to the CNS. We performed a comparison between SEC and differential ultracentrifugation (UC) isolation protocols in terms of yield, contaminants, and transgene expression efficiency. We found that SEC allows a higher recovery of EV-AAVs, free of cell contaminating proteins and with less solo AAVs than UC. Remarkably, SEC-purified EV-AAVs also showed to be more potent at transgene expression than solo AAVs in neuronal cell lines. EV-AAVs exhibited the ability to cross the BBB in neonatal mice upon intravenous administration. In conclusion, SEC-purified brain-targeting EV-AAVs show to be a promising gene delivery vector for therapy of brain disorders. Graphical Abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=200 SRC="FIGDIR/small/542901v1_ufig1.gif" ALT="Figure 1"> View larger version (70K): org.highwire.dtl.DTLVardef@7016b8org.highwire.dtl.DTLVardef@e3a5f3org.highwire.dtl.DTLVardef@1a43286org.highwire.dtl.DTLVardef@f110c5_HPS_FORMAT_FIGEXP M_FIG C_FIG During the production of AAV vectors, a small percentage of AAVs is secreted in association with extracellular vesicles, named "EV-AAVs". EV-AAVs can be efficiently isolated by size exclusion chromatography (SEC). When intravenously injected in mice, brain targeting EV-AAVs can cross the blood brain barrier (BBB) and transduce neuronal cells.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

1
Molecular Therapy - Methods & Clinical Development
38 papers in training set
Top 0.1%
36.6%
2
Molecular Therapy Methods & Clinical Development
13 papers in training set
Top 0.1%
6.3%
3
Nature Communications
5641 papers in training set
Top 25%
6.3%
4
Molecular Therapy
81 papers in training set
Top 0.3%
4.9%
50% of probability mass above
5
Molecular Therapy Nucleic Acids
39 papers in training set
Top 0.2%
4.1%
6
Journal of Controlled Release
44 papers in training set
Top 0.3%
4.1%
7
Scientific Reports
3612 papers in training set
Top 32%
3.3%
8
eLife
5828 papers in training set
Top 48%
1.8%
9
International Journal of Molecular Sciences
494 papers in training set
Top 8%
1.7%
10
Journal of Extracellular Vesicles
55 papers in training set
Top 0.3%
1.5%
11
PLOS ONE
5266 papers in training set
Top 52%
1.5%
12
iScience
1154 papers in training set
Top 24%
1.1%
13
Antiviral Research
50 papers in training set
Top 0.5%
1.1%
14
Viruses
332 papers in training set
Top 3%
1.1%
15
Journal of Neuroscience Methods
122 papers in training set
Top 1%
1.1%
16
PLOS Pathogens
820 papers in training set
Top 8%
1.1%
17
Proceedings of the National Academy of Sciences
2444 papers in training set
Top 39%
0.9%
18
Journal of Virology
499 papers in training set
Top 3%
0.9%
19
Frontiers in Bioengineering and Biotechnology
98 papers in training set
Top 2%
0.9%
20
Bioconjugate Chemistry
20 papers in training set
Top 0.3%
0.9%
21
Cells
249 papers in training set
Top 7%
0.9%
22
Molecular Therapy - Nucleic Acids
25 papers in training set
Top 0.6%
0.9%
23
Science Advances
1243 papers in training set
Top 32%
0.6%
24
ACS Synthetic Biology
287 papers in training set
Top 3%
0.6%
25
Nucleic Acids Research
1281 papers in training set
Top 14%
0.6%
26
Journal of Translational Medicine
57 papers in training set
Top 3%
0.6%